nodes	percent_of_prediction	percent_of_DWPC	metapath
Bezafibrate—CYP1A1—Progesterone—uterine cancer	0.168	0.288	CbGbCtD
Bezafibrate—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.146	0.251	CbGbCtD
Bezafibrate—CYP2C8—Progesterone—uterine cancer	0.0969	0.166	CbGbCtD
Bezafibrate—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0593	0.102	CbGbCtD
Bezafibrate—CYP2C8—Etoposide—uterine cancer	0.0434	0.0744	CbGbCtD
Bezafibrate—CYP3A4—Progesterone—uterine cancer	0.0393	0.0674	CbGbCtD
Bezafibrate—CYP3A4—Etoposide—uterine cancer	0.0176	0.0302	CbGbCtD
Bezafibrate—CYP3A4—Doxorubicin—uterine cancer	0.012	0.0206	CbGbCtD
Bezafibrate—PPARG—artery—uterine cancer	0.00579	0.0494	CbGeAlD
Bezafibrate—PPARD—uterine cervix—uterine cancer	0.00464	0.0396	CbGeAlD
Bezafibrate—PPARG—Teniposide—Etoposide—uterine cancer	0.00459	1	CbGdCrCtD
Bezafibrate—PPARD—decidua—uterine cancer	0.00442	0.0377	CbGeAlD
Bezafibrate—Transaminases increased—Progesterone—uterine cancer	0.00436	0.0252	CcSEcCtD
Bezafibrate—PPARD—mammalian vulva—uterine cancer	0.00406	0.0346	CbGeAlD
Bezafibrate—PPARA—epithelium—uterine cancer	0.00399	0.034	CbGeAlD
Bezafibrate—Cholelithiasis—Medroxyprogesterone Acetate—uterine cancer	0.00387	0.0223	CcSEcCtD
Bezafibrate—PPARA—smooth muscle tissue—uterine cancer	0.00385	0.0328	CbGeAlD
Bezafibrate—Glyburide—ABCC9—uterine cancer	0.00378	0.493	CrCbGaD
Bezafibrate—PPARA—renal system—uterine cancer	0.0037	0.0316	CbGeAlD
Bezafibrate—Cholestasis—Progesterone—uterine cancer	0.0035	0.0202	CcSEcCtD
Bezafibrate—PPARD—female reproductive system—uterine cancer	0.00348	0.0297	CbGeAlD
Bezafibrate—HMGCR—myometrium—uterine cancer	0.00338	0.0289	CbGeAlD
Bezafibrate—PPARD—female gonad—uterine cancer	0.00317	0.027	CbGeAlD
Bezafibrate—PPARD—vagina—uterine cancer	0.00315	0.0268	CbGeAlD
Bezafibrate—PPARA—female reproductive system—uterine cancer	0.00296	0.0253	CbGeAlD
Bezafibrate—PPARA—female gonad—uterine cancer	0.0027	0.023	CbGeAlD
Bezafibrate—HMGCR—epithelium—uterine cancer	0.00266	0.0227	CbGeAlD
Bezafibrate—HMGCR—uterine cervix—uterine cancer	0.00263	0.0225	CbGeAlD
Bezafibrate—HMGCR—smooth muscle tissue—uterine cancer	0.00256	0.0218	CbGeAlD
Bezafibrate—HMGCR—decidua—uterine cancer	0.00251	0.0214	CbGeAlD
Bezafibrate—HMGCR—renal system—uterine cancer	0.00246	0.021	CbGeAlD
Bezafibrate—Indomethacin—AKR1C3—uterine cancer	0.00243	0.317	CrCbGaD
Bezafibrate—Phosphatase alkaline increased—Medroxyprogesterone Acetate—uterine cancer	0.00241	0.0139	CcSEcCtD
Bezafibrate—HMGCR—endometrium—uterine cancer	0.00238	0.0203	CbGeAlD
Bezafibrate—SLCO1B1—renal system—uterine cancer	0.00236	0.0201	CbGeAlD
Bezafibrate—HMGCR—mammalian vulva—uterine cancer	0.0023	0.0196	CbGeAlD
Bezafibrate—HMGCR—uterus—uterine cancer	0.00219	0.0187	CbGeAlD
Bezafibrate—PPARG—epithelium—uterine cancer	0.00219	0.0187	CbGeAlD
Bezafibrate—Vascular purpura—Progesterone—uterine cancer	0.00215	0.0124	CcSEcCtD
Bezafibrate—PPARG—smooth muscle tissue—uterine cancer	0.00211	0.018	CbGeAlD
Bezafibrate—PPARG—decidua—uterine cancer	0.00207	0.0177	CbGeAlD
Bezafibrate—PPARG—renal system—uterine cancer	0.00204	0.0174	CbGeAlD
Bezafibrate—PPARD—lymph node—uterine cancer	0.00204	0.0174	CbGeAlD
Bezafibrate—Blood alkaline phosphatase increased—Medroxyprogesterone Acetate—uterine cancer	0.00201	0.0116	CcSEcCtD
Bezafibrate—Purpura—Progesterone—uterine cancer	0.002	0.0115	CcSEcCtD
Bezafibrate—HMGCR—female reproductive system—uterine cancer	0.00197	0.0168	CbGeAlD
Bezafibrate—PPARG—mammalian vulva—uterine cancer	0.0019	0.0162	CbGeAlD
Bezafibrate—Migraine—Progesterone—uterine cancer	0.0019	0.0109	CcSEcCtD
Bezafibrate—SLCO1B1—female reproductive system—uterine cancer	0.00189	0.0161	CbGeAlD
Bezafibrate—PPARG—uterus—uterine cancer	0.00181	0.0155	CbGeAlD
Bezafibrate—Purpura—Medroxyprogesterone Acetate—uterine cancer	0.00181	0.0105	CcSEcCtD
Bezafibrate—HMGCR—female gonad—uterine cancer	0.0018	0.0153	CbGeAlD
Bezafibrate—Infection—Carboplatin—uterine cancer	0.00179	0.0103	CcSEcCtD
Bezafibrate—HMGCR—vagina—uterine cancer	0.00178	0.0152	CbGeAlD
Bezafibrate—Liver function test abnormal—Progesterone—uterine cancer	0.00178	0.0103	CcSEcCtD
Bezafibrate—Aspartate aminotransferase increased—Progesterone—uterine cancer	0.00174	0.01	CcSEcCtD
Bezafibrate—Cramp muscle—Progesterone—uterine cancer	0.00174	0.01	CcSEcCtD
Bezafibrate—PPARA—lymph node—uterine cancer	0.00173	0.0148	CbGeAlD
Bezafibrate—Migraine—Medroxyprogesterone Acetate—uterine cancer	0.00172	0.00992	CcSEcCtD
Bezafibrate—Gastritis—Progesterone—uterine cancer	0.00171	0.00984	CcSEcCtD
Bezafibrate—Alanine aminotransferase increased—Progesterone—uterine cancer	0.0017	0.00981	CcSEcCtD
Bezafibrate—Blood creatinine increased—Medroxyprogesterone Acetate—uterine cancer	0.00164	0.00944	CcSEcCtD
Bezafibrate—PPARG—female reproductive system—uterine cancer	0.00163	0.0139	CbGeAlD
Bezafibrate—Bronchitis—Progesterone—uterine cancer	0.0016	0.00924	CcSEcCtD
Bezafibrate—Cramp muscle—Medroxyprogesterone Acetate—uterine cancer	0.00157	0.00907	CcSEcCtD
Bezafibrate—Myositis—Epirubicin—uterine cancer	0.00155	0.00896	CcSEcCtD
Bezafibrate—Pain—Carboplatin—uterine cancer	0.00154	0.0089	CcSEcCtD
Bezafibrate—Muscular weakness—Medroxyprogesterone Acetate—uterine cancer	0.00154	0.00889	CcSEcCtD
Bezafibrate—Alanine aminotransferase increased—Medroxyprogesterone Acetate—uterine cancer	0.00154	0.00889	CcSEcCtD
Bezafibrate—Influenza—Medroxyprogesterone Acetate—uterine cancer	0.00151	0.00871	CcSEcCtD
Bezafibrate—PPARG—female gonad—uterine cancer	0.00148	0.0127	CbGeAlD
Bezafibrate—PPARG—vagina—uterine cancer	0.00147	0.0126	CbGeAlD
Bezafibrate—Indomethacin—CXCL8—uterine cancer	0.00146	0.19	CrCbGaD
Bezafibrate—Bronchitis—Medroxyprogesterone Acetate—uterine cancer	0.00145	0.00837	CcSEcCtD
Bezafibrate—Myositis—Doxorubicin—uterine cancer	0.00144	0.00829	CcSEcCtD
Bezafibrate—Phosphatase alkaline increased—Etoposide—uterine cancer	0.00136	0.00784	CcSEcCtD
Bezafibrate—CYP2C8—renal system—uterine cancer	0.00134	0.0114	CbGeAlD
Bezafibrate—CYP1A1—epithelium—uterine cancer	0.00134	0.0114	CbGeAlD
Bezafibrate—Acute coronary syndrome—Medroxyprogesterone Acetate—uterine cancer	0.00133	0.00765	CcSEcCtD
Bezafibrate—CYP1A1—uterine cervix—uterine cancer	0.00132	0.0113	CbGeAlD
Bezafibrate—Pharyngitis—Progesterone—uterine cancer	0.00132	0.00763	CcSEcCtD
Bezafibrate—Myocardial infarction—Medroxyprogesterone Acetate—uterine cancer	0.00132	0.00761	CcSEcCtD
Bezafibrate—Urinary tract disorder—Progesterone—uterine cancer	0.00132	0.0076	CcSEcCtD
Bezafibrate—Urethral disorder—Progesterone—uterine cancer	0.00131	0.00754	CcSEcCtD
Bezafibrate—CYP2C8—endometrium—uterine cancer	0.0013	0.0111	CbGeAlD
Bezafibrate—Erythema multiforme—Progesterone—uterine cancer	0.00126	0.00727	CcSEcCtD
Bezafibrate—Liver function test abnormal—Dactinomycin—uterine cancer	0.00126	0.00726	CcSEcCtD
Bezafibrate—Transaminases increased—Epirubicin—uterine cancer	0.00125	0.00722	CcSEcCtD
Bezafibrate—CYP1A1—renal system—uterine cancer	0.00124	0.0106	CbGeAlD
Bezafibrate—Serum creatinine increased—Epirubicin—uterine cancer	0.00124	0.00714	CcSEcCtD
Bezafibrate—Toxic epidermal necrolysis—Dactinomycin—uterine cancer	0.00123	0.00708	CcSEcCtD
Bezafibrate—Aspartate aminotransferase increased—Dactinomycin—uterine cancer	0.00123	0.00708	CcSEcCtD
Bezafibrate—Pharyngitis—Medroxyprogesterone Acetate—uterine cancer	0.0012	0.00692	CcSEcCtD
Bezafibrate—Urinary tract disorder—Medroxyprogesterone Acetate—uterine cancer	0.00119	0.00688	CcSEcCtD
Bezafibrate—Urethral disorder—Medroxyprogesterone Acetate—uterine cancer	0.00118	0.00683	CcSEcCtD
Bezafibrate—Alopecia—Progesterone—uterine cancer	0.00118	0.0068	CcSEcCtD
Bezafibrate—Erythema—Progesterone—uterine cancer	0.00116	0.0067	CcSEcCtD
Bezafibrate—CYP1A1—mammalian vulva—uterine cancer	0.00116	0.00988	CbGeAlD
Bezafibrate—Transaminases increased—Doxorubicin—uterine cancer	0.00116	0.00668	CcSEcCtD
Bezafibrate—HMGCR—lymph node—uterine cancer	0.00115	0.00984	CbGeAlD
Bezafibrate—Serum creatinine increased—Doxorubicin—uterine cancer	0.00115	0.00661	CcSEcCtD
Bezafibrate—Flatulence—Progesterone—uterine cancer	0.00114	0.0066	CcSEcCtD
Bezafibrate—Erythema multiforme—Medroxyprogesterone Acetate—uterine cancer	0.00114	0.00659	CcSEcCtD
Bezafibrate—Blood alkaline phosphatase increased—Etoposide—uterine cancer	0.00113	0.00654	CcSEcCtD
Bezafibrate—Pancytopenia—Dactinomycin—uterine cancer	0.00112	0.00645	CcSEcCtD
Bezafibrate—Muscle spasms—Progesterone—uterine cancer	0.00112	0.00644	CcSEcCtD
Bezafibrate—CYP1A1—uterus—uterine cancer	0.0011	0.00941	CbGeAlD
Bezafibrate—CYP2C8—female reproductive system—uterine cancer	0.00107	0.00917	CbGeAlD
Bezafibrate—Anaemia—Progesterone—uterine cancer	0.00107	0.00619	CcSEcCtD
Bezafibrate—Alopecia—Medroxyprogesterone Acetate—uterine cancer	0.00107	0.00616	CcSEcCtD
Bezafibrate—Erythema—Medroxyprogesterone Acetate—uterine cancer	0.00105	0.00607	CcSEcCtD
Bezafibrate—Stevens-Johnson syndrome—Dactinomycin—uterine cancer	0.00104	0.006	CcSEcCtD
Bezafibrate—Flatulence—Medroxyprogesterone Acetate—uterine cancer	0.00104	0.00598	CcSEcCtD
Bezafibrate—Muscle spasms—Medroxyprogesterone Acetate—uterine cancer	0.00101	0.00583	CcSEcCtD
Bezafibrate—CYP1A1—female reproductive system—uterine cancer	0.000992	0.00846	CbGeAlD
Bezafibrate—Myalgia—Progesterone—uterine cancer	0.000988	0.0057	CcSEcCtD
Bezafibrate—Anaemia—Medroxyprogesterone Acetate—uterine cancer	0.000972	0.00561	CcSEcCtD
Bezafibrate—CYP2C8—vagina—uterine cancer	0.000972	0.00829	CbGeAlD
Bezafibrate—PPARG—lymph node—uterine cancer	0.000954	0.00813	CbGeAlD
Bezafibrate—Infection—Progesterone—uterine cancer	0.000941	0.00543	CcSEcCtD
Bezafibrate—Pharyngitis—Dactinomycin—uterine cancer	0.000935	0.0054	CcSEcCtD
Bezafibrate—CYP3A4—renal system—uterine cancer	0.000909	0.00775	CbGeAlD
Bezafibrate—CYP1A1—female gonad—uterine cancer	0.000903	0.0077	CbGeAlD
Bezafibrate—CYP1A1—vagina—uterine cancer	0.000897	0.00765	CbGeAlD
Bezafibrate—Myalgia—Medroxyprogesterone Acetate—uterine cancer	0.000895	0.00517	CcSEcCtD
Bezafibrate—Erythema multiforme—Dactinomycin—uterine cancer	0.000891	0.00514	CcSEcCtD
Bezafibrate—Toxic epidermal necrolysis—Etoposide—uterine cancer	0.000888	0.00512	CcSEcCtD
Bezafibrate—Cramp muscle—Etoposide—uterine cancer	0.000888	0.00512	CcSEcCtD
Bezafibrate—Alanine aminotransferase increased—Etoposide—uterine cancer	0.00087	0.00502	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Progesterone—uterine cancer	0.000863	0.00498	CcSEcCtD
Bezafibrate—Insomnia—Progesterone—uterine cancer	0.000857	0.00494	CcSEcCtD
Bezafibrate—Infection—Medroxyprogesterone Acetate—uterine cancer	0.000853	0.00492	CcSEcCtD
Bezafibrate—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.00084	0.00485	CcSEcCtD
Bezafibrate—Dyspepsia—Progesterone—uterine cancer	0.000834	0.00481	CcSEcCtD
Bezafibrate—Alopecia—Dactinomycin—uterine cancer	0.000833	0.0048	CcSEcCtD
Bezafibrate—Erythema—Dactinomycin—uterine cancer	0.00082	0.00473	CcSEcCtD
Bezafibrate—Constipation—Progesterone—uterine cancer	0.00081	0.00467	CcSEcCtD
Bezafibrate—Pain—Progesterone—uterine cancer	0.00081	0.00467	CcSEcCtD
Bezafibrate—Pancytopenia—Etoposide—uterine cancer	0.000809	0.00467	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000782	0.00451	CcSEcCtD
Bezafibrate—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.000776	0.00448	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Progesterone—uterine cancer	0.000775	0.00447	CcSEcCtD
Bezafibrate—Phosphatase alkaline increased—Epirubicin—uterine cancer	0.000761	0.00439	CcSEcCtD
Bezafibrate—Anaemia—Dactinomycin—uterine cancer	0.000758	0.00437	CcSEcCtD
Bezafibrate—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.000756	0.00436	CcSEcCtD
Bezafibrate—Stevens-Johnson syndrome—Etoposide—uterine cancer	0.000753	0.00435	CcSEcCtD
Bezafibrate—Urticaria—Progesterone—uterine cancer	0.000753	0.00434	CcSEcCtD
Bezafibrate—Acute coronary syndrome—Etoposide—uterine cancer	0.000749	0.00432	CcSEcCtD
Bezafibrate—Abdominal pain—Progesterone—uterine cancer	0.000749	0.00432	CcSEcCtD
Bezafibrate—Myocardial infarction—Etoposide—uterine cancer	0.000745	0.0043	CcSEcCtD
Bezafibrate—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.000734	0.00423	CcSEcCtD
Bezafibrate—CYP3A4—female reproductive system—uterine cancer	0.000728	0.00621	CbGeAlD
Bezafibrate—Phosphatase alkaline increased—Doxorubicin—uterine cancer	0.000704	0.00406	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.000702	0.00405	CcSEcCtD
Bezafibrate—Myalgia—Dactinomycin—uterine cancer	0.000698	0.00403	CcSEcCtD
Bezafibrate—Hypersensitivity—Progesterone—uterine cancer	0.000698	0.00403	CcSEcCtD
Bezafibrate—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000682	0.00393	CcSEcCtD
Bezafibrate—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000679	0.00391	CcSEcCtD
Bezafibrate—Urinary tract disorder—Etoposide—uterine cancer	0.000674	0.00389	CcSEcCtD
Bezafibrate—Pruritus—Progesterone—uterine cancer	0.00067	0.00387	CcSEcCtD
Bezafibrate—Urethral disorder—Etoposide—uterine cancer	0.000669	0.00386	CcSEcCtD
Bezafibrate—Infection—Dactinomycin—uterine cancer	0.000665	0.00384	CcSEcCtD
Bezafibrate—Thrombocytopenia—Dactinomycin—uterine cancer	0.000656	0.00378	CcSEcCtD
Bezafibrate—Diarrhoea—Progesterone—uterine cancer	0.000648	0.00374	CcSEcCtD
Bezafibrate—Erythema multiforme—Etoposide—uterine cancer	0.000645	0.00372	CcSEcCtD
Bezafibrate—Blood alkaline phosphatase increased—Epirubicin—uterine cancer	0.000635	0.00367	CcSEcCtD
Bezafibrate—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000632	0.00365	CcSEcCtD
Bezafibrate—Photosensitivity—Epirubicin—uterine cancer	0.000629	0.00363	CcSEcCtD
Bezafibrate—Dizziness—Progesterone—uterine cancer	0.000626	0.00361	CcSEcCtD
Bezafibrate—Vascular purpura—Epirubicin—uterine cancer	0.000618	0.00356	CcSEcCtD
Bezafibrate—Eczema—Epirubicin—uterine cancer	0.000615	0.00355	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.00061	0.00352	CcSEcCtD
Bezafibrate—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000607	0.0035	CcSEcCtD
Bezafibrate—Alopecia—Etoposide—uterine cancer	0.000603	0.00348	CcSEcCtD
Bezafibrate—Renal failure acute—Epirubicin—uterine cancer	0.000599	0.00345	CcSEcCtD
Bezafibrate—Rash—Progesterone—uterine cancer	0.000597	0.00345	CcSEcCtD
Bezafibrate—Dermatitis—Progesterone—uterine cancer	0.000597	0.00344	CcSEcCtD
Bezafibrate—Headache—Progesterone—uterine cancer	0.000593	0.00342	CcSEcCtD
Bezafibrate—Blood alkaline phosphatase increased—Doxorubicin—uterine cancer	0.000588	0.00339	CcSEcCtD
Bezafibrate—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000587	0.00339	CcSEcCtD
Bezafibrate—Photosensitivity—Doxorubicin—uterine cancer	0.000582	0.00336	CcSEcCtD
Bezafibrate—CYP1A1—lymph node—uterine cancer	0.00058	0.00495	CbGeAlD
Bezafibrate—Purpura—Epirubicin—uterine cancer	0.000573	0.00331	CcSEcCtD
Bezafibrate—Pain—Dactinomycin—uterine cancer	0.000573	0.0033	CcSEcCtD
Bezafibrate—Vascular purpura—Doxorubicin—uterine cancer	0.000572	0.0033	CcSEcCtD
Bezafibrate—Muscle spasms—Etoposide—uterine cancer	0.000571	0.00329	CcSEcCtD
Bezafibrate—Eczema—Doxorubicin—uterine cancer	0.000569	0.00328	CcSEcCtD
Bezafibrate—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000568	0.00327	CcSEcCtD
Bezafibrate—Nausea—Progesterone—uterine cancer	0.000563	0.00325	CcSEcCtD
Bezafibrate—Renal failure acute—Doxorubicin—uterine cancer	0.000554	0.0032	CcSEcCtD
Bezafibrate—Anaemia—Etoposide—uterine cancer	0.000549	0.00317	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000547	0.00316	CcSEcCtD
Bezafibrate—Migraine—Epirubicin—uterine cancer	0.000544	0.00314	CcSEcCtD
Bezafibrate—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000541	0.00312	CcSEcCtD
Bezafibrate—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000541	0.00312	CcSEcCtD
Bezafibrate—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000538	0.0031	CcSEcCtD
Bezafibrate—Purpura—Doxorubicin—uterine cancer	0.000531	0.00306	CcSEcCtD
Bezafibrate—Abdominal pain—Dactinomycin—uterine cancer	0.000529	0.00305	CcSEcCtD
Bezafibrate—Blood creatinine increased—Epirubicin—uterine cancer	0.000518	0.00299	CcSEcCtD
Bezafibrate—Liver function test abnormal—Epirubicin—uterine cancer	0.00051	0.00294	CcSEcCtD
Bezafibrate—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00051	0.00294	CcSEcCtD
Bezafibrate—Migraine—Doxorubicin—uterine cancer	0.000503	0.0029	CcSEcCtD
Bezafibrate—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.000498	0.00287	CcSEcCtD
Bezafibrate—Aspartate aminotransferase increased—Epirubicin—uterine cancer	0.000498	0.00287	CcSEcCtD
Bezafibrate—Hypersensitivity—Dactinomycin—uterine cancer	0.000493	0.00285	CcSEcCtD
Bezafibrate—Gastritis—Epirubicin—uterine cancer	0.000489	0.00282	CcSEcCtD
Bezafibrate—Muscular weakness—Epirubicin—uterine cancer	0.000487	0.00281	CcSEcCtD
Bezafibrate—Alanine aminotransferase increased—Epirubicin—uterine cancer	0.000487	0.00281	CcSEcCtD
Bezafibrate—Infection—Etoposide—uterine cancer	0.000481	0.00278	CcSEcCtD
Bezafibrate—Blood creatinine increased—Doxorubicin—uterine cancer	0.000479	0.00276	CcSEcCtD
Bezafibrate—Influenza—Epirubicin—uterine cancer	0.000478	0.00276	CcSEcCtD
Bezafibrate—Thrombocytopenia—Etoposide—uterine cancer	0.000474	0.00274	CcSEcCtD
Bezafibrate—Liver function test abnormal—Doxorubicin—uterine cancer	0.000472	0.00272	CcSEcCtD
Bezafibrate—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.00046	0.00266	CcSEcCtD
Bezafibrate—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.00046	0.00266	CcSEcCtD
Bezafibrate—Bronchitis—Epirubicin—uterine cancer	0.000459	0.00265	CcSEcCtD
Bezafibrate—Diarrhoea—Dactinomycin—uterine cancer	0.000458	0.00264	CcSEcCtD
Bezafibrate—Pancytopenia—Epirubicin—uterine cancer	0.000454	0.00262	CcSEcCtD
Bezafibrate—Gastritis—Doxorubicin—uterine cancer	0.000453	0.00261	CcSEcCtD
Bezafibrate—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.000451	0.0026	CcSEcCtD
Bezafibrate—Muscular weakness—Doxorubicin—uterine cancer	0.000451	0.0026	CcSEcCtD
Bezafibrate—Influenza—Doxorubicin—uterine cancer	0.000442	0.00255	CcSEcCtD
Bezafibrate—Photosensitivity reaction—Epirubicin—uterine cancer	0.000436	0.00252	CcSEcCtD
Bezafibrate—Bronchitis—Doxorubicin—uterine cancer	0.000425	0.00245	CcSEcCtD
Bezafibrate—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000422	0.00244	CcSEcCtD
Bezafibrate—Rash—Dactinomycin—uterine cancer	0.000422	0.00244	CcSEcCtD
Bezafibrate—Pancytopenia—Doxorubicin—uterine cancer	0.00042	0.00242	CcSEcCtD
Bezafibrate—Pain—Etoposide—uterine cancer	0.000414	0.00239	CcSEcCtD
Bezafibrate—Constipation—Etoposide—uterine cancer	0.000414	0.00239	CcSEcCtD
Bezafibrate—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000403	0.00233	CcSEcCtD
Bezafibrate—Nausea—Dactinomycin—uterine cancer	0.000398	0.00229	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Etoposide—uterine cancer	0.000396	0.00229	CcSEcCtD
Bezafibrate—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000391	0.00225	CcSEcCtD
Bezafibrate—Urticaria—Etoposide—uterine cancer	0.000385	0.00222	CcSEcCtD
Bezafibrate—Abdominal pain—Etoposide—uterine cancer	0.000383	0.00221	CcSEcCtD
Bezafibrate—Pharyngitis—Epirubicin—uterine cancer	0.000379	0.00219	CcSEcCtD
Bezafibrate—Urinary tract disorder—Epirubicin—uterine cancer	0.000378	0.00218	CcSEcCtD
Bezafibrate—Urethral disorder—Epirubicin—uterine cancer	0.000375	0.00216	CcSEcCtD
Bezafibrate—Erythema multiforme—Epirubicin—uterine cancer	0.000361	0.00209	CcSEcCtD
Bezafibrate—Hypersensitivity—Etoposide—uterine cancer	0.000357	0.00206	CcSEcCtD
Bezafibrate—Pharyngitis—Doxorubicin—uterine cancer	0.000351	0.00203	CcSEcCtD
Bezafibrate—Urinary tract disorder—Doxorubicin—uterine cancer	0.000349	0.00202	CcSEcCtD
Bezafibrate—Urethral disorder—Doxorubicin—uterine cancer	0.000347	0.002	CcSEcCtD
Bezafibrate—Pruritus—Etoposide—uterine cancer	0.000343	0.00198	CcSEcCtD
Bezafibrate—Alopecia—Epirubicin—uterine cancer	0.000338	0.00195	CcSEcCtD
Bezafibrate—Erythema multiforme—Doxorubicin—uterine cancer	0.000334	0.00193	CcSEcCtD
Bezafibrate—Erythema—Epirubicin—uterine cancer	0.000333	0.00192	CcSEcCtD
Bezafibrate—Diarrhoea—Etoposide—uterine cancer	0.000332	0.00191	CcSEcCtD
Bezafibrate—Flatulence—Epirubicin—uterine cancer	0.000328	0.00189	CcSEcCtD
Bezafibrate—Dizziness—Etoposide—uterine cancer	0.00032	0.00185	CcSEcCtD
Bezafibrate—Muscle spasms—Epirubicin—uterine cancer	0.00032	0.00185	CcSEcCtD
Bezafibrate—Alopecia—Doxorubicin—uterine cancer	0.000313	0.0018	CcSEcCtD
Bezafibrate—Erythema—Doxorubicin—uterine cancer	0.000308	0.00178	CcSEcCtD
Bezafibrate—Anaemia—Epirubicin—uterine cancer	0.000308	0.00177	CcSEcCtD
Bezafibrate—Rash—Etoposide—uterine cancer	0.000306	0.00176	CcSEcCtD
Bezafibrate—Dermatitis—Etoposide—uterine cancer	0.000305	0.00176	CcSEcCtD
Bezafibrate—Headache—Etoposide—uterine cancer	0.000304	0.00175	CcSEcCtD
Bezafibrate—Flatulence—Doxorubicin—uterine cancer	0.000303	0.00175	CcSEcCtD
Bezafibrate—Muscle spasms—Doxorubicin—uterine cancer	0.000296	0.00171	CcSEcCtD
Bezafibrate—Nausea—Etoposide—uterine cancer	0.000288	0.00166	CcSEcCtD
Bezafibrate—Anaemia—Doxorubicin—uterine cancer	0.000285	0.00164	CcSEcCtD
Bezafibrate—Myalgia—Epirubicin—uterine cancer	0.000283	0.00163	CcSEcCtD
Bezafibrate—Infection—Epirubicin—uterine cancer	0.00027	0.00156	CcSEcCtD
Bezafibrate—Thrombocytopenia—Epirubicin—uterine cancer	0.000266	0.00153	CcSEcCtD
Bezafibrate—Myalgia—Doxorubicin—uterine cancer	0.000262	0.00151	CcSEcCtD
Bezafibrate—Infection—Doxorubicin—uterine cancer	0.00025	0.00144	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000247	0.00143	CcSEcCtD
Bezafibrate—Thrombocytopenia—Doxorubicin—uterine cancer	0.000246	0.00142	CcSEcCtD
Bezafibrate—Insomnia—Epirubicin—uterine cancer	0.000246	0.00142	CcSEcCtD
Bezafibrate—Dyspepsia—Epirubicin—uterine cancer	0.000239	0.00138	CcSEcCtD
Bezafibrate—Pain—Epirubicin—uterine cancer	0.000232	0.00134	CcSEcCtD
Bezafibrate—Constipation—Epirubicin—uterine cancer	0.000232	0.00134	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000229	0.00132	CcSEcCtD
Bezafibrate—Insomnia—Doxorubicin—uterine cancer	0.000227	0.00131	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Epirubicin—uterine cancer	0.000222	0.00128	CcSEcCtD
Bezafibrate—Dyspepsia—Doxorubicin—uterine cancer	0.000221	0.00128	CcSEcCtD
Bezafibrate—Urticaria—Epirubicin—uterine cancer	0.000216	0.00124	CcSEcCtD
Bezafibrate—Pain—Doxorubicin—uterine cancer	0.000215	0.00124	CcSEcCtD
Bezafibrate—Constipation—Doxorubicin—uterine cancer	0.000215	0.00124	CcSEcCtD
Bezafibrate—Abdominal pain—Epirubicin—uterine cancer	0.000215	0.00124	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000206	0.00119	CcSEcCtD
Bezafibrate—Hypersensitivity—Epirubicin—uterine cancer	0.0002	0.00115	CcSEcCtD
Bezafibrate—Urticaria—Doxorubicin—uterine cancer	0.0002	0.00115	CcSEcCtD
Bezafibrate—Abdominal pain—Doxorubicin—uterine cancer	0.000199	0.00115	CcSEcCtD
Bezafibrate—Pruritus—Epirubicin—uterine cancer	0.000192	0.00111	CcSEcCtD
Bezafibrate—Diarrhoea—Epirubicin—uterine cancer	0.000186	0.00107	CcSEcCtD
Bezafibrate—Hypersensitivity—Doxorubicin—uterine cancer	0.000185	0.00107	CcSEcCtD
Bezafibrate—Dizziness—Epirubicin—uterine cancer	0.00018	0.00104	CcSEcCtD
Bezafibrate—Pruritus—Doxorubicin—uterine cancer	0.000178	0.00103	CcSEcCtD
Bezafibrate—Diarrhoea—Doxorubicin—uterine cancer	0.000172	0.000992	CcSEcCtD
Bezafibrate—Rash—Epirubicin—uterine cancer	0.000171	0.000988	CcSEcCtD
Bezafibrate—Dermatitis—Epirubicin—uterine cancer	0.000171	0.000987	CcSEcCtD
Bezafibrate—Headache—Epirubicin—uterine cancer	0.00017	0.000982	CcSEcCtD
Bezafibrate—Dizziness—Doxorubicin—uterine cancer	0.000166	0.000959	CcSEcCtD
Bezafibrate—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—uterine cancer	0.000163	0.00143	CbGpPWpGaD
Bezafibrate—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000163	0.00142	CbGpPWpGaD
Bezafibrate—Nausea—Epirubicin—uterine cancer	0.000161	0.000931	CcSEcCtD
Bezafibrate—PPARG—Gene Expression—SUZ12—uterine cancer	0.000161	0.00141	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.000159	0.00139	CbGpPWpGaD
Bezafibrate—CYP3A4—Metapathway biotransformation—AKR1B1—uterine cancer	0.000159	0.00139	CbGpPWpGaD
Bezafibrate—HMGCR—Integrated Breast Cancer Pathway—KRAS—uterine cancer	0.000159	0.00139	CbGpPWpGaD
Bezafibrate—Rash—Doxorubicin—uterine cancer	0.000158	0.000914	CcSEcCtD
Bezafibrate—Dermatitis—Doxorubicin—uterine cancer	0.000158	0.000913	CcSEcCtD
Bezafibrate—PPARA—Metabolism—STAR—uterine cancer	0.000158	0.00138	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—AKR1B1—uterine cancer	0.000158	0.00138	CbGpPWpGaD
Bezafibrate—Headache—Doxorubicin—uterine cancer	0.000157	0.000908	CcSEcCtD
Bezafibrate—PPARG—Metabolism—NDUFB11—uterine cancer	0.000157	0.00137	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—SRD5A2—uterine cancer	0.000157	0.00137	CbGpPWpGaD
Bezafibrate—PPARG—Adipogenesis—CTNNB1—uterine cancer	0.000157	0.00137	CbGpPWpGaD
Bezafibrate—PPARA—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—uterine cancer	0.000157	0.00137	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	0.000156	0.00137	CbGpPWpGaD
Bezafibrate—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—uterine cancer	0.000156	0.00137	CbGpPWpGaD
Bezafibrate—CYP1A1—Aryl Hydrocarbon Receptor—NRAS—uterine cancer	0.000154	0.00135	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—AKR1C1—uterine cancer	0.000152	0.00133	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	0.000152	0.00133	CbGpPWpGaD
Bezafibrate—PPARA—Generic Transcription Pathway—SMAD3—uterine cancer	0.000152	0.00133	CbGpPWpGaD
Bezafibrate—PPARA—Circadian rythm related genes—PTEN—uterine cancer	0.00015	0.00132	CbGpPWpGaD
Bezafibrate—Nausea—Doxorubicin—uterine cancer	0.000149	0.000861	CcSEcCtD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	0.000147	0.00129	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—PGR—uterine cancer	0.000147	0.00129	CbGpPWpGaD
Bezafibrate—PPARG—Generic Transcription Pathway—ESR2—uterine cancer	0.000147	0.00129	CbGpPWpGaD
Bezafibrate—PPARG—SREBP signalling—AKT1—uterine cancer	0.000146	0.00128	CbGpPWpGaD
Bezafibrate—CYP1A1—Biological oxidations—CYP19A1—uterine cancer	0.000144	0.00126	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	0.000144	0.00126	CbGpPWpGaD
Bezafibrate—PPARA—Circadian rythm related genes—EP300—uterine cancer	0.000143	0.00125	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—SMAD3—uterine cancer	0.000143	0.00125	CbGpPWpGaD
Bezafibrate—CYP1A1—Metapathway biotransformation—CYP19A1—uterine cancer	0.000142	0.00124	CbGpPWpGaD
Bezafibrate—HMGCR—Integrated Breast Cancer Pathway—TP53—uterine cancer	0.000141	0.00123	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—EZH2—uterine cancer	0.00014	0.00122	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—RRM2—uterine cancer	0.000136	0.00119	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—POLD1—uterine cancer	0.000136	0.00119	CbGpPWpGaD
Bezafibrate—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000134	0.00117	CbGpPWpGaD
Bezafibrate—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	0.000133	0.00116	CbGpPWpGaD
Bezafibrate—CYP2C8—Biological oxidations—CYP19A1—uterine cancer	0.000132	0.00116	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—DCN—uterine cancer	0.000132	0.00115	CbGpPWpGaD
Bezafibrate—CYP2C8—Metapathway biotransformation—CYP19A1—uterine cancer	0.00013	0.00114	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—ESR2—uterine cancer	0.00013	0.00113	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—AKR1C1—uterine cancer	0.000127	0.00111	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.000126	0.0011	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.000126	0.0011	CbGpPWpGaD
Bezafibrate—PPARA—Generic Transcription Pathway—ESR1—uterine cancer	0.000124	0.00109	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—CYP11A1—uterine cancer	0.000124	0.00109	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—POLD1—uterine cancer	0.000124	0.00109	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—NDUFB11—uterine cancer	0.000124	0.00108	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—SRD5A2—uterine cancer	0.000124	0.00108	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	0.00012	0.00105	CbGpPWpGaD
Bezafibrate—PPARG—Generic Transcription Pathway—CDKN2B—uterine cancer	0.00012	0.00105	CbGpPWpGaD
Bezafibrate—HMGCR—Integrated Breast Cancer Pathway—AKT1—uterine cancer	0.000119	0.00104	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—MET—uterine cancer	0.000118	0.00103	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—AKR1C3—uterine cancer	0.000117	0.00103	CbGpPWpGaD
Bezafibrate—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	0.000117	0.00102	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—AKR1C1—uterine cancer	0.000116	0.00102	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.000115	0.00101	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.000115	0.00101	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—AKR1B1—uterine cancer	0.000113	0.000993	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—STAR—uterine cancer	0.000113	0.000993	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	0.000113	0.000992	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—RRM2—uterine cancer	0.000113	0.000991	CbGpPWpGaD
Bezafibrate—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	0.000113	0.000988	CbGpPWpGaD
Bezafibrate—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—uterine cancer	0.000112	0.000982	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	0.000112	0.000981	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—PGR—uterine cancer	0.000112	0.000981	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—DCN—uterine cancer	0.00011	0.000962	CbGpPWpGaD
Bezafibrate—PPARG—Generic Transcription Pathway—SMAD3—uterine cancer	0.000109	0.000955	CbGpPWpGaD
Bezafibrate—PPARG—Circadian rythm related genes—PTEN—uterine cancer	0.000108	0.000943	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—EZH2—uterine cancer	0.000106	0.000931	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—CDKN2B—uterine cancer	0.000105	0.000923	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—RRM2—uterine cancer	0.000104	0.000906	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—CYP11A1—uterine cancer	0.000104	0.000906	CbGpPWpGaD
Bezafibrate—PPARG—Circadian rythm related genes—EP300—uterine cancer	0.000103	0.000899	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—SMAD3—uterine cancer	0.000103	0.000899	CbGpPWpGaD
Bezafibrate—PPARA—Circadian rythm related genes—TP53—uterine cancer	0.000103	0.000898	CbGpPWpGaD
Bezafibrate—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	0.000102	0.000896	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—DCN—uterine cancer	0.000101	0.00088	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—ESR2—uterine cancer	9.87e-05	0.000863	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—AKR1C3—uterine cancer	9.78e-05	0.000856	CbGpPWpGaD
Bezafibrate—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	9.64e-05	0.000843	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—SMAD3—uterine cancer	9.63e-05	0.000842	CbGpPWpGaD
Bezafibrate—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	9.51e-05	0.000832	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—CYP11A1—uterine cancer	9.47e-05	0.000829	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	9.23e-05	0.000807	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—STK11—uterine cancer	9.15e-05	0.0008	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—CYP19A1—uterine cancer	9.15e-05	0.0008	CbGpPWpGaD
Bezafibrate—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	8.98e-05	0.000786	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—AKR1C3—uterine cancer	8.94e-05	0.000783	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—STAR—uterine cancer	8.93e-05	0.000782	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—AKR1B1—uterine cancer	8.93e-05	0.000782	CbGpPWpGaD
Bezafibrate—PPARG—Generic Transcription Pathway—ESR1—uterine cancer	8.91e-05	0.000779	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—POLD1—uterine cancer	8.9e-05	0.000779	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	8.83e-05	0.000773	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—ERBB2—uterine cancer	8.59e-05	0.000751	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	8.59e-05	0.000751	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	8.46e-05	0.00074	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—MET—uterine cancer	8.42e-05	0.000737	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—AKR1C1—uterine cancer	8.33e-05	0.000728	CbGpPWpGaD
Bezafibrate—CYP1A1—PPARA activates gene expression—EP300—uterine cancer	8.22e-05	0.000719	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism of lipids and lipoproteins—EP300—uterine cancer	8.19e-05	0.000716	CbGpPWpGaD
Bezafibrate—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—uterine cancer	8.04e-05	0.000704	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—PGR—uterine cancer	8.03e-05	0.000703	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—CDKN2B—uterine cancer	8.03e-05	0.000703	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—ESR1—uterine cancer	7.86e-05	0.000687	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—NDUFB11—uterine cancer	7.74e-05	0.000678	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—SRD5A2—uterine cancer	7.74e-05	0.000678	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—EZH2—uterine cancer	7.63e-05	0.000668	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—STK11—uterine cancer	7.62e-05	0.000667	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—CYP19A1—uterine cancer	7.62e-05	0.000667	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	7.52e-05	0.000658	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—CTNNB1—uterine cancer	7.51e-05	0.000657	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—RRM2—uterine cancer	7.42e-05	0.000649	CbGpPWpGaD
Bezafibrate—PPARG—Circadian rythm related genes—TP53—uterine cancer	7.35e-05	0.000643	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—SMAD3—uterine cancer	7.33e-05	0.000642	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—DCN—uterine cancer	7.2e-05	0.00063	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	7.15e-05	0.000626	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	7.1e-05	0.000622	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—SRD5A2—uterine cancer	7.1e-05	0.000621	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—NDUFB11—uterine cancer	7.1e-05	0.000621	CbGpPWpGaD
Bezafibrate—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	7.09e-05	0.00062	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—ESR2—uterine cancer	7.07e-05	0.000619	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—POLD1—uterine cancer	7.01e-05	0.000613	CbGpPWpGaD
Bezafibrate—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	6.99e-05	0.000612	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—EP300—uterine cancer	6.98e-05	0.000611	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—STK11—uterine cancer	6.97e-05	0.00061	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—CYP19A1—uterine cancer	6.97e-05	0.00061	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	6.9e-05	0.000603	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—MTHFR—uterine cancer	6.87e-05	0.000601	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism of lipids and lipoproteins—EP300—uterine cancer	6.82e-05	0.000597	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—CYP11A1—uterine cancer	6.79e-05	0.000594	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—VEGFA—uterine cancer	6.62e-05	0.000579	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—AKR1C1—uterine cancer	6.56e-05	0.000574	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	6.54e-05	0.000572	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—NRAS—uterine cancer	6.53e-05	0.000572	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	6.51e-05	0.00057	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—AKR1C3—uterine cancer	6.41e-05	0.000561	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism of lipids and lipoproteins—EP300—uterine cancer	6.24e-05	0.000546	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—ERBB2—uterine cancer	6.16e-05	0.000539	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	6.06e-05	0.00053	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—ESR1—uterine cancer	5.99e-05	0.000524	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—RRM2—uterine cancer	5.84e-05	0.000511	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—CDKN2B—uterine cancer	5.76e-05	0.000504	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—MTHFR—uterine cancer	5.73e-05	0.000501	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—DCN—uterine cancer	5.67e-05	0.000496	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—KRAS—uterine cancer	5.62e-05	0.000492	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—AKR1B1—uterine cancer	5.6e-05	0.00049	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—STAR—uterine cancer	5.6e-05	0.00049	CbGpPWpGaD
Bezafibrate—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—uterine cancer	5.54e-05	0.000485	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	5.53e-05	0.000484	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—CTNNB1—uterine cancer	5.39e-05	0.000471	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—CYP11A1—uterine cancer	5.34e-05	0.000468	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—SMAD3—uterine cancer	5.26e-05	0.00046	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—MTHFR—uterine cancer	5.24e-05	0.000458	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—STAR—uterine cancer	5.13e-05	0.000449	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—AKR1B1—uterine cancer	5.13e-05	0.000449	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	5.07e-05	0.000444	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—AKR1C3—uterine cancer	5.05e-05	0.000442	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	5.05e-05	0.000441	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—EP300—uterine cancer	5.01e-05	0.000438	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—STK11—uterine cancer	4.99e-05	0.000437	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—CYP19A1—uterine cancer	4.99e-05	0.000437	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—HRAS—uterine cancer	4.78e-05	0.000418	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—VEGFA—uterine cancer	4.74e-05	0.000415	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	4.69e-05	0.00041	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—NRAS—uterine cancer	4.68e-05	0.00041	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.61e-05	0.000404	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4.47e-05	0.000391	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—POLD1—uterine cancer	4.39e-05	0.000384	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—ESR1—uterine cancer	4.29e-05	0.000375	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—AKT1—uterine cancer	4.22e-05	0.000369	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—AKR1C1—uterine cancer	4.11e-05	0.00036	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—KRAS—uterine cancer	4.03e-05	0.000353	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—POLD1—uterine cancer	4.03e-05	0.000352	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—STK11—uterine cancer	3.93e-05	0.000344	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—CYP19A1—uterine cancer	3.93e-05	0.000344	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—PTEN—uterine cancer	3.82e-05	0.000335	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—NDUFB11—uterine cancer	3.81e-05	0.000333	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—SRD5A2—uterine cancer	3.81e-05	0.000333	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—AKR1C1—uterine cancer	3.77e-05	0.00033	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—MTHFR—uterine cancer	3.75e-05	0.000328	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	3.69e-05	0.000323	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—RRM2—uterine cancer	3.66e-05	0.00032	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—EP300—uterine cancer	3.65e-05	0.000319	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—DCN—uterine cancer	3.56e-05	0.000311	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	3.52e-05	0.000308	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—HRAS—uterine cancer	3.43e-05	0.0003	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—RRM2—uterine cancer	3.36e-05	0.000294	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CYP11A1—uterine cancer	3.35e-05	0.000293	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.31e-05	0.000289	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—DCN—uterine cancer	3.26e-05	0.000285	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—PTEN—uterine cancer	3.18e-05	0.000279	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—AKR1C3—uterine cancer	3.16e-05	0.000277	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CYP11A1—uterine cancer	3.07e-05	0.000269	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—EP300—uterine cancer	3.04e-05	0.000266	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—AKT1—uterine cancer	3.02e-05	0.000265	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—MTHFR—uterine cancer	2.95e-05	0.000259	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—PTEN—uterine cancer	2.91e-05	0.000255	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—AKR1C3—uterine cancer	2.9e-05	0.000254	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—AKT1—uterine cancer	2.83e-05	0.000248	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—EP300—uterine cancer	2.78e-05	0.000243	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—STAR—uterine cancer	2.76e-05	0.000241	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—AKR1B1—uterine cancer	2.76e-05	0.000241	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—PIK3CA—uterine cancer	2.7e-05	0.000236	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.6e-05	0.000228	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—STK11—uterine cancer	2.46e-05	0.000216	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CYP19A1—uterine cancer	2.46e-05	0.000216	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.31e-05	0.000202	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—STK11—uterine cancer	2.26e-05	0.000198	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CYP19A1—uterine cancer	2.26e-05	0.000198	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—PIK3CA—uterine cancer	2.25e-05	0.000197	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.21e-05	0.000193	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—AKT1—uterine cancer	2.2e-05	0.000193	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—POLD1—uterine cancer	2.16e-05	0.000189	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—AKT1—uterine cancer	2.16e-05	0.000189	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.12e-05	0.000186	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PTEN—uterine cancer	2.09e-05	0.000183	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—PIK3CA—uterine cancer	2.06e-05	0.00018	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.02e-05	0.000177	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—AKR1C1—uterine cancer	2.02e-05	0.000177	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—EP300—uterine cancer	1.99e-05	0.000174	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—MTHFR—uterine cancer	1.85e-05	0.000162	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—AKT1—uterine cancer	1.84e-05	0.000161	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—RRM2—uterine cancer	1.8e-05	0.000158	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—DCN—uterine cancer	1.75e-05	0.000153	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—MTHFR—uterine cancer	1.7e-05	0.000149	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—AKT1—uterine cancer	1.68e-05	0.000147	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CYP11A1—uterine cancer	1.65e-05	0.000144	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PTEN—uterine cancer	1.64e-05	0.000144	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.63e-05	0.000143	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—EP300—uterine cancer	1.57e-05	0.000137	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—AKR1C3—uterine cancer	1.56e-05	0.000136	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—AKT1—uterine cancer	1.55e-05	0.000135	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.5e-05	0.000131	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PIK3CA—uterine cancer	1.47e-05	0.000129	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—STK11—uterine cancer	1.21e-05	0.000106	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CYP19A1—uterine cancer	1.21e-05	0.000106	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—AKT1—uterine cancer	1.2e-05	0.000105	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PIK3CA—uterine cancer	1.16e-05	0.000101	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PTEN—uterine cancer	1.03e-05	9.01e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—EP300—uterine cancer	9.83e-06	8.6e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—AKT1—uterine cancer	9.47e-06	8.29e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PTEN—uterine cancer	9.45e-06	8.26e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—MTHFR—uterine cancer	9.11e-06	7.97e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—EP300—uterine cancer	9.01e-06	7.88e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PIK3CA—uterine cancer	7.27e-06	6.36e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PIK3CA—uterine cancer	6.66e-06	5.83e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—AKT1—uterine cancer	5.94e-06	5.2e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—AKT1—uterine cancer	5.44e-06	4.76e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PTEN—uterine cancer	5.07e-06	4.44e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—EP300—uterine cancer	4.84e-06	4.23e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PIK3CA—uterine cancer	3.58e-06	3.13e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—AKT1—uterine cancer	2.92e-06	2.56e-05	CbGpPWpGaD
